P2Y2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines-Reference-Cited by-同舟云学术

P2Y2 receptors mediate nucleotide-induced EGFR phosphorylation and stimulate proliferation and tumorigenesis of head and neck squamous cell carcinoma cell lines

Published:2020-10 Issue: Volume:109 Page:104808
ISSN:1368-8375
Container-title:Oral Oncology
language:en
Short-container-title:Oral Oncology

Author:

Woods Lucas T.,Jasmer Kimberly J.,Muñoz Forti Kevin,Shanbhag Vinit C.,Camden Jean M.,Erb Laurie,Petris Michael J.,Weisman Gary A.

Funder

National Institute of Dental & Craniofacial Research

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Oral Surgery

Reference58 articles.

1. Epidemiologic trends in head and neck cancer and aids in diagnosis;Vigneswaran;Oral Maxillofac Surg Clin North Am,2014

2. cancer epidemic and human papillomavirus;Ramqvist;Emerg Infect Dis,2010

3. The molecular landscape of head and neck cancer;Leemans;Nat Rev Cancer,2018

4. Locoregionally recurrent head and neck squamous cell carcinoma: incidence, survival, prognostic factors, and treatment outcomes;Chang;Oncotarget,2017

5. Optimizing treatments for recurrent or metastatic head and neck squamous cell carcinoma;Specenier;Expert Rev Anticancer Ther,2018

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of the role of purinergic signaling and insights into its role in cancer therapy;Pharmacology & Therapeutics;2024-10

2. Design, Synthesis, and Evaluation of a New Chemotype Fluorescent Ligand for the P2Y₂ Receptor;ACS Medicinal Chemistry Letters;2024-06-12

3. Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets;Molecules;2024-03-20

4. Comprehensive insights into potential roles of purinergic P2 receptors on diseases: Signaling pathways involved and potential therapeutics;Journal of Advanced Research;2024-03

5. Role and clinical significance of immunogenic cell death biomarkers in chemoresistance and immunoregulation of head and neck squamous cell carcinoma;Biomedicine & Pharmacotherapy;2023-11